March 12, 2012

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah

Sections

Spotlight
Martin Plaehn

Spotlight
Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

TechKnowledge
In the Lab

EntrepreneurEdge
Rent to Own

Business Trends
Back from the Dead

Executive Living
Artful Inspiration

Features
A Breath of Fresh Air

Features
Worst-Case Scenario

Regional Report
Northern Utah

Focus
Measure Up

Industry Outlook
Travel & Tourism

Players
Players

Article

Catheter Connections Announces a Patent Notice of Allowance

Press Release

March 12, 2012

Catheter Connections announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application that broadly covers a method of disinfecting IV tubing end connectors. Upon issuance, the patent will expire no earlier than 2029. A family of corresponding patent applications is pending in the U.S. and internationally.

Landmark clinical evidence shows that the IV tubing end connector (a male “luer lock” connector) is susceptible to microbial contamination and routinely causes cross-contamination between IV connectors. Studies also confirm that biofilm, which is responsible for the majority of blood stream infections, forms on these connectors and that a contaminated connector will transfer microbes into a patient’s IV catheter. The Company is now selling DualCap, the only FDA-cleared device for disinfection and protection of both the IV catheter needleless luer access valve and the IV tubing end connector.

Catheter Connections was the first to recognize and demonstrate that the IV tubing end connector is a vector of microbial contamination and is a significant risk factor for hospital-acquired infections. “This patent issuance is particularly valuable because it confirms that we were the first to innovate a medical device solution unlike any other. It further protects the platform technology underlying the Company’s DualCap System and is an indicator of the dominant position we expect to achieve worldwide,” said Vicki Farrar, Esq., CEO of Catheter Connections.

Each year more than 500,000 patients in U.S. hospitals suffer from IV catheter-related blood stream infections and up to one in four patients die as a result. Due to the preventability of these infections, insurers no longer reimburse hospitals for treating them, costing hospitals up to $11 billion annually; hospitals lose an average of $47,000 per infection.

The traditional method of disinfecting IV access valves using an alcohol swab to scrub the valve surface, currently in place at the majority of U.S. hospitals, is insufficient. This method does not disinfect the IV tubing end connector. Even if valves are scrubbed, the variability in scrubbing technique among clinicians leads to inconsistent valve disinfection. The DualCap System is the only integrated solution that addresses these deficiencies.

Utah Business Social
UB Events View All
30 Women to Watch 2014!Utah Business Event
May 22, 2014
Thirty of Utah’s most dynamic women will be recognized at the 15th Annual 30 Women to Watch Awar...
Community Events View All
Branding Utah
Apr 18, 2014
Vicki Varela, managing director for the Utah Office of Tourism, Film and Global Branding, will sh...
Excel Level 1
Apr 22, 2014
A hands-on, interactive class covering Microsoft Excel fundamentals. Explore the new user interfa...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
Date(s):
to
* Event Description:
  Cancel